Streetbeat News

Stock Prices

GRTX

Galera Therapeutics Inc (GRTX) stock is sinking after the FDA reiterated the need for an additional Phase 3 trial of avasopasem manganese for radiotherapy-induced severe oral mucositis. The company also decided to halt the Phase 2b GRECO-2 trial of rucosopasem manganese in patients with locally advanced pancreatic cancer and the Phase 1/2 GRECO-1 trial of rucosopasem in patients with non-small-cell-lung-cancer, following futility analysis of the GRECO-2 trial. The company's shares are down 51.90% at $0.10.

Portfolio Pulse from Vandana Singh

October 31, 2023 | 1:58 pm

SIEN

Trading of Sientra's shares has resumed.

Portfolio Pulse from Benzinga Newsdesk

October 31, 2023 | 1:57 pm

CHK

Chesapeake Energy Corporation (NYSE:CHK) is set to release its Q3 financial results on Oct. 31, 2023. Analysts predict a quarterly earnings of 64 cents per share, down from $5.06 per share in the previous year. The company's revenue is expected to be $1.2 billion, compared to $2.01 billion in the year-ago period. Analysts from Benchmark, Wells Fargo, JP Morgan, Stephens & Co., and UBS have recently revised their ratings and price targets for the company.

Portfolio Pulse from Lisa Levin

October 31, 2023 | 1:55 pm

ABBV

AMGN

Amgen Inc reported Q3 FY23 sales of $6.90 billion, slightly missing the consensus of $6.94 billion. Total revenues increased 4% Y/Y, driven by a 5% increase in product sales. Adjusted EPS increased 6% to $4.96, beating the consensus of $4.66. However, the company's stock fell by 3.78%. Amgen also raised its FY23 adjusted EPS and revenue guidance. Sales of Amjevita, Amgen's new biosimilar version of AbbVie Inc's arthritis drug Humira, rose 30% to $152 million.

Portfolio Pulse from Vandana Singh

October 31, 2023 | 1:55 pm

SIEN

Shares of Sientra (SIEN) have been halted on a circuit breaker due to a significant drop in the stock price. The stock is currently down by 51.4%.

Portfolio Pulse from Benzinga Newsdesk

October 31, 2023 | 1:52 pm

AVTX

CDIO

GRTX

KTRA

PFE

SPRC

SRPT

US stocks traded lower following the release of economic reports. Pfizer Inc reported a Q3 loss with a 42% slump in sales. SciSparc Ltd, Cardio Diagnostics Holdings, and Avalo Therapeutics saw their shares rise after positive news, while Kintara Therapeutics, Galera Therapeutics, and Sarepta Therapeutics saw their shares drop due to negative developments.

Portfolio Pulse from Lisa Levin

October 31, 2023 | 1:52 pm

CCJ

Investor Business Daily SwingTrader has reportedly purchased stock in Cameco, a uranium mining company. This could potentially influence the stock's performance in the short term.

Portfolio Pulse from Benzinga Newsdesk

October 31, 2023 | 1:47 pm

GPN

Global Payments Inc (GPN) reported Q3 FY23 results with a 9% Y/Y increase in adjusted net revenue to $2.232 billion, slightly beating the consensus of $2.226 billion. The company also raised its adjusted EPS outlook for FY23 and is progressing with the integration of EVO Payments. GPN shares are trading higher by around 2%.

Portfolio Pulse from Lekha Gupta

October 31, 2023 | 1:46 pm

SIRI

Sirius XM Holdings Inc reported a flat Q3 FY23 revenue of $2.27 billion, slightly missing the consensus of $2.29 billion. Adjusted EPS of $0.09 beat the consensus of $0.08. Subscriber and advertising revenue remained steady. The company reiterated its FY23 revenue outlook of $9.0 billion. SIRI shares traded higher by 4.90% at $4.39.

Portfolio Pulse from Anusuya Lahiri

October 31, 2023 | 1:46 pm

SPY

The Chicago Purchasing Managers' Index (PMI) for October came in at 44, lower than the estimated 45 and the prior figure of 44.1. This indicates a contraction in the manufacturing sector in the Chicago region.

Portfolio Pulse from Benzinga Newsdesk

October 31, 2023 | 1:45 pm